Szöőr Árpád
DE >
ÁOKegyetemi gyakornok 2008-
Teljes publikációs lista
Publikációs időszak:
2005-2024
2024
Nagy, L.,
Mezősi-Csaplár, M.,
Rebenku, I.,
Vereb, G.,
Szöőr, Á.:
Universal CAR T cells targeted to HER2 with a biotin-trastuzumab soluble linker penetrate spheroids and large tumor xenografts that are inherently resistant to trastuzumab mediated ADCC.
Front. Immunol. 15 1-38, 2024.
Folyóirat-mutatók:
Q1 Immunology (2022)
Q1 Immunology and Allergy (2022)
2023
Barden, M.,
Holzinger, A.,
Velas, L.,
Mezősi-Csaplár, M.,
Szöőr, Á.,
Vereb, G.,
Schütz, G.,
Hombach, A.,
Abken, H.:
CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in T cell activation.
Front. Immunol. 14 1-13, 2023.
Folyóirat-mutatók:
Q1 Immunology (2022)
Q1 Immunology and Allergy (2022)
Csiki, D.,
Ababneh, H.,
Tóth, A.,
Lente, G.,
Szöőr, Á.,
Tóth, A.,
Fillér, C.,
Juhász, T.,
Nagy, B.,
Balogh, E.,
Jeney, V.:
Hypoxia-inducible factor activation promotes osteogenic transition of valve interstitial cells and accelerates aortic valve calcification in a mice model of chronic kidney disease.
Front. Cardiovasc. Med. 10 1-15, 2023.
Folyóirat-mutatók:
Q1 Cardiology and Cardiovascular Medicine (2022)
2022
Tóth, A.,
Csiki, D.,
Nagy, B.,
Balogh, E.,
Lente, G.,
Ababneh, H.,
Szöőr, Á.,
Jeney, V.:
Daprodustat Accelerates High Phosphate-Induced Calcification Through the Activation of HIF-1 Signaling.
Front. Pharmacol. 13 1-12, 2022.
Folyóirat-mutatók:
Q1 Pharmacology
Q1 Pharmacology (medical)
Cserepes, M.,
Nelhűbel, G.,
Meilinger-Dobra, M.,
Herczeg, A.,
Türk, D.,
Hegedűs, Z.,
Svajda, L.,
Rásó, E.,
Ladányi, A.,
Csikó, K.,
Kenessey, I.,
Szöőr, Á.,
Vereb, G.,
Remenár, É.,
Tóvári, J.:
EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer.
Cancers (Basel). 14 (10), 1-15, 2022.
Folyóirat-mutatók:
Q2 Cancer Research
Q1 Oncology
Bencze, D.,
Fekete, T.,
Pfliegler, V.,
Szöőr, Á.,
Csoma, E.,
Szántó, A.,
Tarr, T.,
Bácsi, A.,
Kemény, L.,
Veréb, Z.,
Pázmándi, K.:
Interactions between the NLRP3-Dependent IL-1β and the Type I Interferon Pathways in Human Plasmacytoid Dendritic Cells.
Int. J. Mol. Sci. 23 (20), 1-34, 2022.
Folyóirat-mutatók:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
Blokon-Kogan, D.,
Levi-Mann, M.,
Malka-Levy, L.,
Itzhaki, O.,
Besser, M.,
Shiftan, Y.,
Szöőr, Á.,
Vereb, G.,
Gross, G.,
Abken, H.,
Weinstein-Marom, H.:
Membrane anchored IL-18 linked to constitutively active TLR4 and CD40 improves human T cell antitumor capacities for adoptive cell therapy.
J Immunother Cancer. 10 (9), 1-12, 2022.
Folyóirat-mutatók:
D1 Cancer Research
D1 Immunology
D1 Immunology and Allergy
D1 Molecular Medicine
D1 Oncology
D1 Pharmacology
Guti, E.,
Regdon, Z.,
Sturniolo, I.,
Kiss, A.,
Kovács, K.,
Demény, M.,
Szöőr, Á.,
Vereb, G.,
Szöllősi, J.,
Hegedűs, C.,
Polgár, Z.,
Virág, L.:
The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC.
Cancer Immunol. Immunother. 71 (9), 2151-2168, 2022.
Folyóirat-mutatók:
Q1 Cancer Research
Q1 Immunology
Q1 Immunology and Allergy
D1 Medicine (miscellaneous)
Q1 Oncology
2021
Mezősi-Csaplár, M.,
Szöllősi, J.,
Gottschalk, S.,
Vereb, G.,
Szöőr, Á.:
Cytolytic Activity of CAR T Cells and Maintenance of Their CD4+ Subset Is Critical for Optimal Antitumor Activity in Preclinical Solid Tumor Models.
Cancers (Basel). 13 (17), 1-19, 2021.
Folyóirat-mutatók:
Q2 Cancer Research
Q1 Oncology
Varga, Z.,
Rácz, E.,
Türk-Mázló, A.,
Korodi, M.,
Szabó, A.,
Molnár, T.,
Szöőr, Á.,
Veréb, Z.,
Bácsi, A.,
Koncz, G.:
Cytotoxic activity of human dendritic cells induces RIPK1-dependent cell death.
Immunobiology. 226 (1), 1-7, 2021.
Folyóirat-mutatók:
Q2 Hematology
Q3 Immunology
Q3 Immunology and Allergy
2020
Tóth, G.,
Szöllősi, J.,
Abken, H.,
Vereb, G.,
Szöőr, Á.:
A Small Number of HER2 Redirected CAR T Cells Significantly Improves Immune Response of Adoptively Transferred Mouse Lymphocytes against Human Breast Cancer Xenografts.
Int. J. Mol. Sci. 21 (3), 1-11, 2020.
Folyóirat-mutatók:
Q2 Catalysis
D1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
D1 Physical and Theoretical Chemistry
D1 Spectroscopy
Volpin, V.,
Michels, T.,
Sorrentino, A.,
Menevse, A.,
Knoll, G.,
Ditz, M.,
Milenkovic, V.,
Chen, C.,
Rathinasamy, A.,
Griewank, K.,
Boutros, M.,
Haferkamp, S.,
Berneburg, M.,
Wetzel, C.,
Seckinger, A.,
Hose, D.,
Goldschmidt, H.,
Ehrenschwender, M.,
Witzens-Harig, M.,
Szöőr, Á.,
Vereb, G.,
Khandelwal, N.,
Beckhove, P.:
CAMK1D Triggers Immune Resistance of Human Tumor Cells Refractory to Anti-PD-L1 Treatment.
Cancer Immunol. Res. 8 1163-1179, 2020.
Folyóirat-mutatók:
D1 Cancer Research
D1 Immunology
Szöőr, Á.,
Tóth, G.,
Zsebik, B.,
Szabó, V.,
Eshhar, Z.,
Abken, H.,
Vereb, G.:
Trastuzumab Derived HER2-specific CARs for the Treatment of Trastuzumab-Resistant Breast Cancer: CAR T Cells Penetrate and Eradicate Tumors That Are Not Accessible to Antibodies.
Cancer Lett. 484 1-8, 2020.
Folyóirat-mutatók:
Q1 Cancer Research
Q1 Oncology
2019
Méhes, E.,
Baráth, M.,
Gulyás, M.,
Bugyik, E.,
Geiszt, M.,
Szöőr, Á.,
Lányi, Á.,
Czirok, A.:
Enhanced endothelial motility and multicellular sprouting is mediated by the scaffold protein TKS4.
Sci. Rep. 9 (1), 1-13, 2019.
Bosire, R.,
Nánási, P.,
Imre, L.,
Dienes, B.,
Szöőr, Á.,
Türk-Mázló, A.,
Kovács, A.,
Seidel, R.,
Vámosi, G.,
Szabó, G.:
Intercalation of small molecules into DNA in chromatin is primarily controlled by superhelical constraint.
PLoS One. 14 (11), e0224936, 2019.
2017
Velasquez, M.,
Szöőr, Á.,
Vaidya, A.,
Thakkar, A.,
Nguyen, T.,
Wu, M.,
Liu, H.,
Gottschalk, S.:
CD28 and 41BB Costimulation Enhances the Effector Function of CD19-Specific Engager T Cells.
Cancer Immunol. Res. 5 (10), 860-870, 2017.
Folyóirat-mutatók:
D1 Cancer Research
D1 Immunology
Szöőr, Á.,
Vaidya, A.,
Velasquez, M.,
Mei, Z.,
Galvan, D.,
Torres, D.,
Gee, A.,
Heczey, A.,
Gottschalk, S.:
T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCC.
Mol. Ther Oncolytics. 28 (6), 69-79, 2017.
Folyóirat-mutatók:
Q2 Cancer Research
Q2 Molecular Medicine
Q2 Oncology
Q1 Pharmacology (medical)
Szöőr, Á.,
Velasquez, M.,
Bonifant, C.,
Vaidya, A.,
Brunetti, L.,
Gundry, M.,
Parihar, R.,
Goodell, M.,
Gottschalk, S.:
Two-pronged Cell Therapy: engineering NK cells to target CD22 and redirect bystander T cells to CD19 for the adoptive immunotherapy of B-cell malignancies.
J. Immunol. 198 (Suppl.), 198,6, 2017.
2016
Bonifant, C.,
Szöőr, Á.,
Torres, D.,
Joseph, N.,
Velasquez, M.,
Iwahori, K.,
Gaikwad, A.,
Nguyen, T.,
Arber, C.,
Song, X.,
Redell, M.,
Gottschalk, S.:
CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia.
Mol. Ther. 24 (9), 1615-1626, 2016.
Folyóirat-mutatók:
D1 Drug Discovery
D1 Genetics
D1 Medicine (miscellaneous)
Q1 Molecular Biology
D1 Molecular Medicine
D1 Pharmacology
Szöőr, Á.,
Ujlaky-Nagy, L.,
Tóth, G.,
Szöllősi, J.,
Vereb, G.:
Cell confluence induces switching from proliferation to migratory signaling by site-selective phosphorylation of PDGF receptors on lipid raft platforms.
Cell. Signal. 28 (2), 81-93, 2016.
Szöőr, Á.,
Mei, Z.,
Gee, A.,
Heczey, A.,
Gottschalk, S.:
T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCC.
Mol. Ther. 24 (Suppl.), S255-S256, 2016.
Velasquez, M.,
Torres, D.,
Iwahori, K.,
Kakarla, S.,
Arber, C.,
Rodriguez-Cruz, T.,
Szöőr, Á.,
Bonifant, C.,
Gerken, C.,
Cooper, L.,
Song, X.,
Gottschalk, S.:
T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive Malignancies.
Sci. Rep. 6 (27130), 1-11, 2016.
2024
Nagy, L.,
Mezősi-Csaplár, M.,
Rebenku, I.,
Vereb, G.,
Szöőr, Á.:
Universal CAR T cells targeted to HER2 with a biotin-trastuzumab soluble linker penetrate spheroids and large tumor xenografts that are inherently resistant to trastuzumab mediated ADCC.
Front. Immunol. 15 1-38, 2024.
Folyóirat-mutatók:
Q1 Immunology (2022)
Q1 Immunology and Allergy (2022)
2023
Barden, M.,
Holzinger, A.,
Velas, L.,
Mezősi-Csaplár, M.,
Szöőr, Á.,
Vereb, G.,
Schütz, G.,
Hombach, A.,
Abken, H.:
CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in T cell activation.
Front. Immunol. 14 1-13, 2023.
Folyóirat-mutatók:
Q1 Immunology (2022)
Q1 Immunology and Allergy (2022)
Csiki, D.,
Ababneh, H.,
Tóth, A.,
Lente, G.,
Szöőr, Á.,
Tóth, A.,
Fillér, C.,
Juhász, T.,
Nagy, B.,
Balogh, E.,
Jeney, V.:
Hypoxia-inducible factor activation promotes osteogenic transition of valve interstitial cells and accelerates aortic valve calcification in a mice model of chronic kidney disease.
Front. Cardiovasc. Med. 10 1-15, 2023.
Folyóirat-mutatók:
Q1 Cardiology and Cardiovascular Medicine (2022)
2022
Tóth, A.,
Csiki, D.,
Nagy, B.,
Balogh, E.,
Lente, G.,
Ababneh, H.,
Szöőr, Á.,
Jeney, V.:
Daprodustat Accelerates High Phosphate-Induced Calcification Through the Activation of HIF-1 Signaling.
Front. Pharmacol. 13 1-12, 2022.
Folyóirat-mutatók:
Q1 Pharmacology
Q1 Pharmacology (medical)
Cserepes, M.,
Nelhűbel, G.,
Meilinger-Dobra, M.,
Herczeg, A.,
Türk, D.,
Hegedűs, Z.,
Svajda, L.,
Rásó, E.,
Ladányi, A.,
Csikó, K.,
Kenessey, I.,
Szöőr, Á.,
Vereb, G.,
Remenár, É.,
Tóvári, J.:
EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer.
Cancers (Basel). 14 (10), 1-15, 2022.
Folyóirat-mutatók:
Q2 Cancer Research
Q1 Oncology
Bencze, D.,
Fekete, T.,
Pfliegler, V.,
Szöőr, Á.,
Csoma, E.,
Szántó, A.,
Tarr, T.,
Bácsi, A.,
Kemény, L.,
Veréb, Z.,
Pázmándi, K.:
Interactions between the NLRP3-Dependent IL-1β and the Type I Interferon Pathways in Human Plasmacytoid Dendritic Cells.
Int. J. Mol. Sci. 23 (20), 1-34, 2022.
Folyóirat-mutatók:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
Blokon-Kogan, D.,
Levi-Mann, M.,
Malka-Levy, L.,
Itzhaki, O.,
Besser, M.,
Shiftan, Y.,
Szöőr, Á.,
Vereb, G.,
Gross, G.,
Abken, H.,
Weinstein-Marom, H.:
Membrane anchored IL-18 linked to constitutively active TLR4 and CD40 improves human T cell antitumor capacities for adoptive cell therapy.
J Immunother Cancer. 10 (9), 1-12, 2022.
Folyóirat-mutatók:
D1 Cancer Research
D1 Immunology
D1 Immunology and Allergy
D1 Molecular Medicine
D1 Oncology
D1 Pharmacology
Guti, E.,
Regdon, Z.,
Sturniolo, I.,
Kiss, A.,
Kovács, K.,
Demény, M.,
Szöőr, Á.,
Vereb, G.,
Szöllősi, J.,
Hegedűs, C.,
Polgár, Z.,
Virág, L.:
The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC.
Cancer Immunol. Immunother. 71 (9), 2151-2168, 2022.
Folyóirat-mutatók:
Q1 Cancer Research
Q1 Immunology
Q1 Immunology and Allergy
D1 Medicine (miscellaneous)
Q1 Oncology
2021
Mezősi-Csaplár, M.,
Szöllősi, J.,
Gottschalk, S.,
Vereb, G.,
Szöőr, Á.:
Cytolytic Activity of CAR T Cells and Maintenance of Their CD4+ Subset Is Critical for Optimal Antitumor Activity in Preclinical Solid Tumor Models.
Cancers (Basel). 13 (17), 1-19, 2021.
Folyóirat-mutatók:
Q2 Cancer Research
Q1 Oncology
Varga, Z.,
Rácz, E.,
Türk-Mázló, A.,
Korodi, M.,
Szabó, A.,
Molnár, T.,
Szöőr, Á.,
Veréb, Z.,
Bácsi, A.,
Koncz, G.:
Cytotoxic activity of human dendritic cells induces RIPK1-dependent cell death.
Immunobiology. 226 (1), 1-7, 2021.
Folyóirat-mutatók:
Q2 Hematology
Q3 Immunology
Q3 Immunology and Allergy
2020
Tóth, G.,
Szöllősi, J.,
Abken, H.,
Vereb, G.,
Szöőr, Á.:
A Small Number of HER2 Redirected CAR T Cells Significantly Improves Immune Response of Adoptively Transferred Mouse Lymphocytes against Human Breast Cancer Xenografts.
Int. J. Mol. Sci. 21 (3), 1-11, 2020.
Folyóirat-mutatók:
Q2 Catalysis
D1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
D1 Physical and Theoretical Chemistry
D1 Spectroscopy
Volpin, V.,
Michels, T.,
Sorrentino, A.,
Menevse, A.,
Knoll, G.,
Ditz, M.,
Milenkovic, V.,
Chen, C.,
Rathinasamy, A.,
Griewank, K.,
Boutros, M.,
Haferkamp, S.,
Berneburg, M.,
Wetzel, C.,
Seckinger, A.,
Hose, D.,
Goldschmidt, H.,
Ehrenschwender, M.,
Witzens-Harig, M.,
Szöőr, Á.,
Vereb, G.,
Khandelwal, N.,
Beckhove, P.:
CAMK1D Triggers Immune Resistance of Human Tumor Cells Refractory to Anti-PD-L1 Treatment.
Cancer Immunol. Res. 8 1163-1179, 2020.
Folyóirat-mutatók:
D1 Cancer Research
D1 Immunology
Szöőr, Á.,
Tóth, G.,
Zsebik, B.,
Szabó, V.,
Eshhar, Z.,
Abken, H.,
Vereb, G.:
Trastuzumab Derived HER2-specific CARs for the Treatment of Trastuzumab-Resistant Breast Cancer: CAR T Cells Penetrate and Eradicate Tumors That Are Not Accessible to Antibodies.
Cancer Lett. 484 1-8, 2020.
Folyóirat-mutatók:
Q1 Cancer Research
Q1 Oncology
2019
Méhes, E.,
Baráth, M.,
Gulyás, M.,
Bugyik, E.,
Geiszt, M.,
Szöőr, Á.,
Lányi, Á.,
Czirok, A.:
Enhanced endothelial motility and multicellular sprouting is mediated by the scaffold protein TKS4.
Sci. Rep. 9 (1), 1-13, 2019.
Bosire, R.,
Nánási, P.,
Imre, L.,
Dienes, B.,
Szöőr, Á.,
Türk-Mázló, A.,
Kovács, A.,
Seidel, R.,
Vámosi, G.,
Szabó, G.:
Intercalation of small molecules into DNA in chromatin is primarily controlled by superhelical constraint.
PLoS One. 14 (11), e0224936, 2019.
2017
Velasquez, M.,
Szöőr, Á.,
Vaidya, A.,
Thakkar, A.,
Nguyen, T.,
Wu, M.,
Liu, H.,
Gottschalk, S.:
CD28 and 41BB Costimulation Enhances the Effector Function of CD19-Specific Engager T Cells.
Cancer Immunol. Res. 5 (10), 860-870, 2017.
Folyóirat-mutatók:
D1 Cancer Research
D1 Immunology
Szöőr, Á.,
Vaidya, A.,
Velasquez, M.,
Mei, Z.,
Galvan, D.,
Torres, D.,
Gee, A.,
Heczey, A.,
Gottschalk, S.:
T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCC.
Mol. Ther Oncolytics. 28 (6), 69-79, 2017.
Folyóirat-mutatók:
Q2 Cancer Research
Q2 Molecular Medicine
Q2 Oncology
Q1 Pharmacology (medical)
Szöőr, Á.,
Velasquez, M.,
Bonifant, C.,
Vaidya, A.,
Brunetti, L.,
Gundry, M.,
Parihar, R.,
Goodell, M.,
Gottschalk, S.:
Two-pronged Cell Therapy: engineering NK cells to target CD22 and redirect bystander T cells to CD19 for the adoptive immunotherapy of B-cell malignancies.
J. Immunol. 198 (Suppl.), 198,6, 2017.
2016
Bonifant, C.,
Szöőr, Á.,
Torres, D.,
Joseph, N.,
Velasquez, M.,
Iwahori, K.,
Gaikwad, A.,
Nguyen, T.,
Arber, C.,
Song, X.,
Redell, M.,
Gottschalk, S.:
CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia.
Mol. Ther. 24 (9), 1615-1626, 2016.
Folyóirat-mutatók:
D1 Drug Discovery
D1 Genetics
D1 Medicine (miscellaneous)
Q1 Molecular Biology
D1 Molecular Medicine
D1 Pharmacology
Szöőr, Á.,
Ujlaky-Nagy, L.,
Tóth, G.,
Szöllősi, J.,
Vereb, G.:
Cell confluence induces switching from proliferation to migratory signaling by site-selective phosphorylation of PDGF receptors on lipid raft platforms.
Cell. Signal. 28 (2), 81-93, 2016.
Szöőr, Á.,
Mei, Z.,
Gee, A.,
Heczey, A.,
Gottschalk, S.:
T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCC.
Mol. Ther. 24 (Suppl.), S255-S256, 2016.
Velasquez, M.,
Torres, D.,
Iwahori, K.,
Kakarla, S.,
Arber, C.,
Rodriguez-Cruz, T.,
Szöőr, Á.,
Bonifant, C.,
Gerken, C.,
Cooper, L.,
Song, X.,
Gottschalk, S.:
T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive Malignancies.
Sci. Rep. 6 (27130), 1-11, 2016.
Tóth, G.,
Szöőr, Á.,
Simon, L.,
Yarden, Y.,
Szöllősi, J.,
Vereb, G.:
The combination of trastuzumab and pertuzumab administered at approved doses may delay development of trastuzumab resistance by additively enhancing antibody-dependent cell-mediated cytotoxicity.
mAbs. 8 (7), 1361-1370, 2016.
Folyóirat-mutatók:
Q2 Immunology
Q1 Immunology and Allergy
2014
Nagy, D.,
Gönczi, M.,
Dienes, B.,
Szöőr, Á.,
Fodor, J.,
Nagy, Z.,
Tóth, A.,
Fodor, T.,
Bai, P.,
Szűcs, G.,
Rusznák, Z.,
Csernoch, L.:
Silencing the KCNK9 potassium channel (TASK-3) gene disturbs mitochondrial function, causes mitochondrial depolarization, and induces apoptosis of human melanoma cells.
Arch. Dermatol. Res. 306 (10), 885-902, 2014.
Folyóirat-mutatók:
Q1 Dermatology
Q1 Medicine (miscellaneous)
Nagy, D.,
Gönczi, M.,
Nagy, Z.,
Tóth, A.,
Dienes, B.,
Fodor, J.,
Szűcs, G.,
Rusznák, Z.,
Szöőr, Á.,
Csernoch, L.:
Stable gene silencing of TASK-3 channels in melanoma cells induce intrinsic apoptosis.
Acta Physiol. 211 (Suppl.), 40, 2014.
Govers, C.,
Sebestyén, Z.,
Roszik, J.,
van Brakel, M.,
Berrevoets, C.,
Szöőr, Á.,
Panoutsopoulou, K.,
Broertjes, M.,
Van, T.,
Vereb, G.,
Szöllősi, J.,
Debets, R.:
TCRs genetically linked to CD28 and CD3[epszilon] do not mispair with endogenous TCR chains and mediate enhanced t cell persistence and anti-melanoma activity.
J. Immunol. 193 (10), 5315-5326, 2014.
2012
Pázmándi, K.,
Kumar, B.,
Szabó, K.,
Boldogh, I.,
Szöőr, Á.,
Vereb, G.,
Rajnavölgyi, É.,
Bácsi, A.:
Parlagfű szubpollen partikulák NAD(P)H oxidáz enzimei által termelt reaktív oxigén gyökök hatásainak vizsgálata humán dendritikus sejteken.
Immunol. Szle. 4 (3), 30, 2012.
Pázmándi, K.,
Kumar, B.,
Szabó, K.,
Boldogh, I.,
Szöőr, Á.,
Vereb, G.,
Veres, Á.,
Lányi, Á.,
Rajnavölgyi, É.,
Bácsi, A.:
Ragweed subpollen particles of respirable size activate human dendritic cells.
PLoS One. 7 (12), e52085, 2012.
Folyóirat-mutatók:
D1 Agricultural and Biological Sciences (miscellaneous)
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1 Medicine (miscellaneous)
Pázmándi, K.,
Kumar, B.,
Szabó, K.,
Boldogh, I.,
Szöőr, Á.,
Vereb, G.,
Veres, Á.,
Lányi, Á.,
Rajnavölgyi, É.,
Bácsi, A.:
Reactive oxygen species generated by NAD(P)H oxidases in ragweed subpollen particles activate human dendritic cells.
Immunology. 137 458, 2012.
2011
Vondalova, B.,
Jelínková, I.,
Szöőr, Á.,
Skender, B.,
Soucek, K.,
Horváth, V.,
Vaculova, A.,
Andera, L.,
Sova, P.,
Szöllősi, J.,
Hofmanova, J.,
Vereb, G.,
Kozubik, A.:
Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway.
Carcinogenesis. 32 (1), 42-51, 2011.
Folyóirat-mutatók:
Q1 Cancer Research
D1 Medicine (miscellaneous)
Roszik, J.,
Sebestyén, Z.,
Govers, C.,
Guri, Y.,
Szöőr, Á.,
Pályiné Krekk, Z.,
Vereb, G.,
Nagy, P.,
Szöllősi, J.,
Debets, R.:
T-cell synapse formation depends on antigen recognition but not CD3 interaction: studies with TCR : zeta, a candidate transgene for TCR gene therapy.
Eur. J. Immunol. 41 (5), 1288-1297, 2011.
Folyóirat-mutatók:
Q1 Immunology
D1 Immunology and Allergy
2010
2005
Mindet mutasd
frissítve: 2024-04-18, 01:07
